83 research outputs found
Re-engineering NASA's space communications to remain viable in a constrained fiscal environment
Along with the Red and Blue Teams commissioned by the NASA Administrator in 1992, NASA's Associate Administrator for Space Communications commissioned a Blue Team to review the Office of Space Communications (Code O) Core Program and determine how the program could be conducted faster, better, and cheaper. Since there was no corresponding Red Team for the Code O Blue Team, the Blue Team assumed a Red Team independent attitude and challenged the status quo, including current work processes, functional distinctions, interfaces, and information flow, as well as traditional management and system development practices. The Blue Team's unconstrained, non-parochial, and imaginative look at NASA's space communications program produced a simplified representation of the space communications infrastructure that transcends organizational and functional boundaries, in addition to existing systems and facilities. Further, the Blue Team adapted the 'faster, better, cheaper' charter to be relevant to the multi-mission, continuous nature of the space communications program and to serve as a gauge for improving customer services concurrent with achieving more efficient operations and infrastructure life cycle economies. This simplified representation, together with the adapted metrics, offers a future view and process model for reengineering NASA's space communications to remain viable in a constrained fiscal environment. Code O remains firm in its commitment to improve productivity, effectiveness, and efficiency. In October 1992, the Associate Administrator reconstituted the Blue Team as the Code O Success Team (COST) to serve as a catalyst for change. In this paper, the COST presents the chronicle and significance of the simplified representation and adapted metrics, and their application during the FY 1993-1994 activities
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4 butanediol (1,4-BD; BDO) : a literature review with a focus on UK fatalities related to non-medical use
Misuse of gamma hydroxybutrate (GHB) and gamma butyrolactone (GBL) has increased greatly since the early 1990s, being implicated in a rising number of deaths. This paper reviews knowledge on GHB and derivatives, and explores the largest series of deaths associated with their non-medical use. Descriptive analyses of cases associated with GHB/GBL and 1,4 butanediol (1,4-BD) use extracted from the UKâs National Programme on Substance Abuse Deaths database. From 1995 to September 2013, 159 GHB/GBL-associated fatalities were reported. Typical victims: White (92%), young (mean age 32 years); male (82%); with a drug misuse history (70%). Most deaths (79%) were accidental or related to drug use, the remainder (potential) suicides. GHB/GBL alone was implicated in 37%; alcohol 14%; other drugs 28%; other drugs and alcohol 15%. Its endogenous nature and rapid elimination limit toxicological detection. Post-mortem blood levels: mean 482 (range 0 - 6500; S.D. 758) mg/L. Results suggest significant caution is needed when ingesting GHB/GBL, particularly with alcohol, benzodiazepines, opiates, stimulants, and ketamine. More awareness is needed about risks associated with consumption.Peer reviewe
Digital pathology for reporting histopathology samples, including cancer screening samples â definitive evidence from a multisite study
Aims
To conduct a definitive multicentre comparison of digital pathology (DP) with light microscopy (LM) for reporting histopathology slides including breast and bowel cancer screening samples.
Methods
A total of 2024 cases (608 breast, 607 GI, 609 skin, 200 renal) were studied, including 207 breast and 250 bowel cancer screening samples. Cases were examined by four pathologists (16 study pathologists across the four speciality groups), using both LM and DP, with the order randomly assigned and 6âweeks between viewings. Reports were compared for clinical management concordance (CMC), meaning identical diagnoses plus differences which do not affect patient management. Percentage CMCs were computed using logistic regression models with crossed random-effects terms for case and pathologist. The obtained percentage CMCs were referenced to 98.3% calculated from previous studies.
Results
For all cases LM versus DP comparisons showed the CMC rates were 99.95% [95% confidence interval (CI)â=â99.90â99.97] and 98.96 (95% CIâ=â98.42â99.32) for cancer screening samples. In speciality groups CMC for LM versus DP showed: breast 99.40% (99.06â99.62) overall and 96.27% (94.63â97.43) for cancer screening samples; [gastrointestinal (GI)â=â99.96% (99.89â99.99)] overall and 99.93% (99.68â99.98) for bowel cancer screening samples; skin 99.99% (99.92â100.0); renal 99.99% (99.57â100.0). Analysis of clinically significant differences revealed discrepancies in areas where interobserver variability is known to be high, in reads performed with both modalities and without apparent trends to either.
Conclusions
Comparing LM and DP CMC, overall rates exceed the reference 98.3%, providing compelling evidence that pathologists provide equivalent results for both routine and cancer screening samples irrespective of the modality used
Surgical induction of posterior vitreous detachment using combined sharp dissection and active aspiration
Graphite and Carbon Fiber Composite for Fusion
2siGraphite and carbon fiber composites have been an historic material for plasma facing components for fusion devices. While the use of this material enhances plasma performance, the harsh plasma and nuclear environment gives rise to a range of physical property changes and materials interactions. High-energy plasma ions can react with and remove the carbon atoms to the plasma. Neutron produced by the fusion reaction will cause structural damage drastically alter the thermophysical properties of the material and enhance tritium trapping. As discussed in this chapter, these factors inherently limit both the lifetime of the plasma facing components and the performance of the devices in which they are applied.reservedmixedFerraris, Monica; Snead, LanceFerraris, Monica; Snead, Lanc
- âŚ